OPEN-SOURCE SCRIPT
SMI Ergodic Oscillator Backtest ver.2
The SMI Ergodic Indicator is the same as the True Strength Index (TSI) developed by
William Blau, except the SMI includes a signal line. The SMI uses double moving averages
of price minus previous price over 2 time frames. The signal line, which is an EMA of the
SMI, is plotted to help trigger trading signals. Adjustable guides are also given to fine
tune these signals. The user may change the input (close), method (EMA), period lengths
and guide values.
You can use in the xPrice any series: Open, High, Low, Close, HL2, HLC3, OHLC4 and ect...
WARNING:
- For purpose educate only
William Blau, except the SMI includes a signal line. The SMI uses double moving averages
of price minus previous price over 2 time frames. The signal line, which is an EMA of the
SMI, is plotted to help trigger trading signals. Adjustable guides are also given to fine
tune these signals. The user may change the input (close), method (EMA), period lengths
and guide values.
You can use in the xPrice any series: Open, High, Low, Close, HL2, HLC3, OHLC4 and ect...
WARNING:
- For purpose educate only
Script de código aberto
Em verdadeiro espírito do TradingView, o criador deste script o tornou de código aberto, para que os traders possam revisar e verificar sua funcionalidade. Parabéns ao autor! Embora você possa usá-lo gratuitamente, lembre-se de que a republicação do código está sujeita às nossas Regras da Casa.
Aviso legal
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Script de código aberto
Em verdadeiro espírito do TradingView, o criador deste script o tornou de código aberto, para que os traders possam revisar e verificar sua funcionalidade. Parabéns ao autor! Embora você possa usá-lo gratuitamente, lembre-se de que a republicação do código está sujeita às nossas Regras da Casa.
Aviso legal
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.